Life Science REIT PLC
LSE:LABS
Cash Flow Statement
Cash Flow Statement
Life Science REIT PLC
| Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|
| Operating Cash Flow | |||||
| Net Income |
(15)
|
(32)
|
(8)
|
(23)
|
|
| Other Non-Cash Items |
23
|
42
|
17
|
34
|
|
| Change in Working Capital |
(1)
|
2
|
3
|
(1)
|
|
| Cash from Operating Activities |
8
N/A
|
12
+55%
|
13
+10%
|
10
-25%
|
|
| Investing Cash Flow | |||||
| Capital Expenditures |
(24)
|
(30)
|
(19)
|
(10)
|
|
| Other Items |
12
|
11
|
3
|
3
|
|
| Cash from Investing Activities |
(12)
N/A
|
(19)
-66%
|
(16)
+15%
|
(7)
+54%
|
|
| Financing Cash Flow | |||||
| Net Issuance of Debt |
(3)
|
17
|
14
|
8
|
|
| Cash Paid for Dividends |
(14)
|
(7)
|
(7)
|
(4)
|
|
| Other |
(10)
|
(12)
|
(12)
|
(12)
|
|
| Cash from Financing Activities |
(27)
N/A
|
(1)
+95%
|
(5)
-322%
|
(8)
-49%
|
|
| Change in Cash | |||||
| Net Change in Cash |
(31)
N/A
|
(9)
+72%
|
(9)
+1%
|
(6)
+34%
|
|
| Free Cash Flow | |||||
| Free Cash Flow |
(16)
N/A
|
(18)
-11%
|
(6)
+65%
|
(1)
+88%
|
|